Article
Molecular mechanisms associated with multiple sclerosis progression, severity and phenotype
2022-10-17
Abstract excerpt
While current treatments of multiple sclerosis (MS) effectively inhibit formation of focal lesions and relapses, most patients experience progression independent of relapse activity (PIRA). To understand PIRA, we analyzed nine prospectively acquired clinical and imaging outcomes in 176 relapsing-remitting and 215 progressive MS patients and 45 healthy volunteers, along with matched cellular and >5000 protein data...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f29a3806-79c5-5d7a-a583-976d65088ff7
- DOI
- 10.1101/2022.10.14.22281095
